High-risk CTV delineation for cervix brachytherapy: Application of GEC-ESTRO guidelines in Australia and New Zealand.

Shalini Kavita VinodKaren LimLauren BellJacqueline VeeraLucy OhanessianEwa JuresicNira BorokPhillip ChanRaphael CheeViet DoGeetha GovindarajuluSwetha SridharanCarol JohnsonDaniel MosesSylvia Van DykLois Holloway

Published in: Journal of medical imaging and radiation oncology (2016)

Delineation of HR-CTV for cervical cancer brachytherapy was consistent amongst observers, suggesting similar interpretation of GEC-ESTRO guidelines. Despite the good concordance, there was dosimetric variation noted, which could be clinically significant.

Keyphrases

radiation therapy
high dose
clinical practice
locally advanced
low dose
squamous cell carcinoma
rectal cancer